Interleukin-1β in human plasma: Optimization of blood collection, plasma extraction, and radioimmunoassay methods

J. G. Cannon, J. W.M. Van Der Meer, D. Kwiatkowski, S. Endres, G. Lonnemann, J. F. Burke, C. A. Dinarello

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Current immunoassays for interleukin-1β (IL-1β) are effective for analyzing fluids derived from cultured cells. However, IL-1β determinations in human plasma or serum samples are technically complicated by higher protein and lipid concentrations, physicochemical differences which exist between samples from healthy subjects and those experiencing acute phase responses, and by the fact that IL-1β can be produced and degraded in the blood collection tube after the sample is drawn. A simple chloroform extraction process has been developed which eliminates several of the interfering factors from plasma samples and increases the amount of IL-1β detected by radioimmunoassay and lymphocyte activation assay. In the radioimmunoassay, rabbit sera was found to influence the accuracy and variability of plasma measurements. Improvements in radioimmunoassay reagents and methods are reported which reduce this influence. Finally, different concentrations of IL-1β were measured depending on whether serum or plasma was tested. We propose that plasma samples collected with EDTA and aprotinin provide a better determination of free circulating IL-1β in vivo than serum samples, which may contain IL-1β secreted from blood leukocytes during the clotting process.

Original languageEnglish (US)
Pages (from-to)457-467
Number of pages11
JournalLymphokine Research
Volume7
Issue number4
StatePublished - Dec 1 1988

Fingerprint

Interleukin-1
Radioimmunoassay
Serum
Acute-Phase Reaction
Aprotinin
Lymphocyte Activation
Chloroform
Immunoassay
Edetic Acid
Cultured Cells
Healthy Volunteers
Leukocytes
Rabbits
Lipids
Proteins

ASJC Scopus subject areas

  • Immunology
  • Hematology

Cite this

Cannon, J. G., Van Der Meer, J. W. M., Kwiatkowski, D., Endres, S., Lonnemann, G., Burke, J. F., & Dinarello, C. A. (1988). Interleukin-1β in human plasma: Optimization of blood collection, plasma extraction, and radioimmunoassay methods. Lymphokine Research, 7(4), 457-467.

Interleukin-1β in human plasma : Optimization of blood collection, plasma extraction, and radioimmunoassay methods. / Cannon, J. G.; Van Der Meer, J. W.M.; Kwiatkowski, D.; Endres, S.; Lonnemann, G.; Burke, J. F.; Dinarello, C. A.

In: Lymphokine Research, Vol. 7, No. 4, 01.12.1988, p. 457-467.

Research output: Contribution to journalArticle

Cannon, JG, Van Der Meer, JWM, Kwiatkowski, D, Endres, S, Lonnemann, G, Burke, JF & Dinarello, CA 1988, 'Interleukin-1β in human plasma: Optimization of blood collection, plasma extraction, and radioimmunoassay methods', Lymphokine Research, vol. 7, no. 4, pp. 457-467.
Cannon JG, Van Der Meer JWM, Kwiatkowski D, Endres S, Lonnemann G, Burke JF et al. Interleukin-1β in human plasma: Optimization of blood collection, plasma extraction, and radioimmunoassay methods. Lymphokine Research. 1988 Dec 1;7(4):457-467.
Cannon, J. G. ; Van Der Meer, J. W.M. ; Kwiatkowski, D. ; Endres, S. ; Lonnemann, G. ; Burke, J. F. ; Dinarello, C. A. / Interleukin-1β in human plasma : Optimization of blood collection, plasma extraction, and radioimmunoassay methods. In: Lymphokine Research. 1988 ; Vol. 7, No. 4. pp. 457-467.
@article{f98ce77969bd424389c6c8d17030576b,
title = "Interleukin-1β in human plasma: Optimization of blood collection, plasma extraction, and radioimmunoassay methods",
abstract = "Current immunoassays for interleukin-1β (IL-1β) are effective for analyzing fluids derived from cultured cells. However, IL-1β determinations in human plasma or serum samples are technically complicated by higher protein and lipid concentrations, physicochemical differences which exist between samples from healthy subjects and those experiencing acute phase responses, and by the fact that IL-1β can be produced and degraded in the blood collection tube after the sample is drawn. A simple chloroform extraction process has been developed which eliminates several of the interfering factors from plasma samples and increases the amount of IL-1β detected by radioimmunoassay and lymphocyte activation assay. In the radioimmunoassay, rabbit sera was found to influence the accuracy and variability of plasma measurements. Improvements in radioimmunoassay reagents and methods are reported which reduce this influence. Finally, different concentrations of IL-1β were measured depending on whether serum or plasma was tested. We propose that plasma samples collected with EDTA and aprotinin provide a better determination of free circulating IL-1β in vivo than serum samples, which may contain IL-1β secreted from blood leukocytes during the clotting process.",
author = "Cannon, {J. G.} and {Van Der Meer}, {J. W.M.} and D. Kwiatkowski and S. Endres and G. Lonnemann and Burke, {J. F.} and Dinarello, {C. A.}",
year = "1988",
month = "12",
day = "1",
language = "English (US)",
volume = "7",
pages = "457--467",
journal = "Journal of Interferon and Cytokine Research",
issn = "1079-9907",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Interleukin-1β in human plasma

T2 - Optimization of blood collection, plasma extraction, and radioimmunoassay methods

AU - Cannon, J. G.

AU - Van Der Meer, J. W.M.

AU - Kwiatkowski, D.

AU - Endres, S.

AU - Lonnemann, G.

AU - Burke, J. F.

AU - Dinarello, C. A.

PY - 1988/12/1

Y1 - 1988/12/1

N2 - Current immunoassays for interleukin-1β (IL-1β) are effective for analyzing fluids derived from cultured cells. However, IL-1β determinations in human plasma or serum samples are technically complicated by higher protein and lipid concentrations, physicochemical differences which exist between samples from healthy subjects and those experiencing acute phase responses, and by the fact that IL-1β can be produced and degraded in the blood collection tube after the sample is drawn. A simple chloroform extraction process has been developed which eliminates several of the interfering factors from plasma samples and increases the amount of IL-1β detected by radioimmunoassay and lymphocyte activation assay. In the radioimmunoassay, rabbit sera was found to influence the accuracy and variability of plasma measurements. Improvements in radioimmunoassay reagents and methods are reported which reduce this influence. Finally, different concentrations of IL-1β were measured depending on whether serum or plasma was tested. We propose that plasma samples collected with EDTA and aprotinin provide a better determination of free circulating IL-1β in vivo than serum samples, which may contain IL-1β secreted from blood leukocytes during the clotting process.

AB - Current immunoassays for interleukin-1β (IL-1β) are effective for analyzing fluids derived from cultured cells. However, IL-1β determinations in human plasma or serum samples are technically complicated by higher protein and lipid concentrations, physicochemical differences which exist between samples from healthy subjects and those experiencing acute phase responses, and by the fact that IL-1β can be produced and degraded in the blood collection tube after the sample is drawn. A simple chloroform extraction process has been developed which eliminates several of the interfering factors from plasma samples and increases the amount of IL-1β detected by radioimmunoassay and lymphocyte activation assay. In the radioimmunoassay, rabbit sera was found to influence the accuracy and variability of plasma measurements. Improvements in radioimmunoassay reagents and methods are reported which reduce this influence. Finally, different concentrations of IL-1β were measured depending on whether serum or plasma was tested. We propose that plasma samples collected with EDTA and aprotinin provide a better determination of free circulating IL-1β in vivo than serum samples, which may contain IL-1β secreted from blood leukocytes during the clotting process.

UR - http://www.scopus.com/inward/record.url?scp=0024255853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024255853&partnerID=8YFLogxK

M3 - Article

C2 - 3145372

AN - SCOPUS:0024255853

VL - 7

SP - 457

EP - 467

JO - Journal of Interferon and Cytokine Research

JF - Journal of Interferon and Cytokine Research

SN - 1079-9907

IS - 4

ER -